Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma

Figure 1 Comparison of recurrence-free survival curves between groups. Patients in group III have significant inferior survival curves compared with the other two groups. The 5-year recurrence-free survival rate was 54.7% (P < 0.0005).

Figure 2 Comparison of overall survival curves between groups. Patients in group III have significant inferior survival curves compared with the other two groups. The 5-year overall survival rate was 56.2% (P = 0.046).

Figure 3 Comparison of recurrence-free survival curves based on the definition of profound tumor necrosis. The recurrence-free survival in patients with profound tumor necrosis (TN) was significantly better than those without profound TN (P = 0.01). TN: Tumor necrosis.

Figure 4 Comparison of overall survival curves based on the definition of profound tumor necrosis. The comparison of overall survival curves was not significantly different in relation to the presence of profound tumor necrosis (P = 0.17).